Mechanisms of secondary hyperparathyroidism

被引:129
作者
Silver, J [1 ]
Kilav, R
Naveh-Many, T
机构
[1] Hadassah Univ Hosp, Serv Nephrol, Minerva Ctr Calcium & Bone Metab, IL-91120 Jerusalem, Israel
[2] Hadassah Univ Hosp, Hypertens Serv, Minerva Ctr Calcium & Bone Metab, IL-91120 Jerusalem, Israel
关键词
parathyroid hormone gene expression; posttranscriptional gene regulation; calcium; phosphate; vitamin D; chronic renal failure;
D O I
10.1152/ajprenal.00061.2002
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Small decreases in serum Ca(2+) and more prolonged increases in serum phosphate (P(i)) stimulate the parathyroid (PT) to secrete parathyroid hormone (PTH), and 1,25(OH)(2)D(3) decreases PTH synthesis and secretion. A prolonged decrease in serum Ca(2+) and 1,25(OH)(2)D(3), or increase in serum P(i), such as in patients with chronic renal failure, leads to the appropriate secondary increase in serum PTH. This secondary hyperparathyroidism involves increases in PTH gene expression, synthesis, and secretion, and if chronic, to proliferation of the PT cells. Low serum Ca(2+) leads to an increase in PTH secretion, PTH mRNA stability, and PT cell proliferation. P(i) also regulates the PT in a similar manner. The effect of Ca(2+) on the PT is mediated by a membrane Ca(2+) receptor. 1,25(OH)(2)D(3) decreases PTH gene transcription. Ca(2+) and P(i) regulate the PTH gene posttranscriptionally by regulating the binding of PT cytosolic proteins, trans factors, to a defined cis sequence in the PTH mRNA 3'-untranslated region, thereby determining the stability of the transcript. PT trans factors and cis elements have been defined.
引用
收藏
页码:F367 / F376
页数:10
相关论文
共 84 条
[1]   Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription [J].
Agarwal, SK ;
Guru, SC ;
Heppner, C ;
Erdos, MR ;
Collins, RM ;
Park, SY ;
Saggar, S ;
Chandrasekharappa, SC ;
Collins, FS ;
Spiegel, AM ;
Marx, SJ ;
Burns, AL .
CELL, 1999, 96 (01) :143-152
[2]  
Almaden Y, 1998, J AM SOC NEPHROL, V9, P1845
[3]  
Almaden Y, 1996, J BONE MINER RES, V11, P970
[4]  
Almadén Y, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133693
[5]  
Almadén Y, 2000, J AM SOC NEPHROL, V11, P1712, DOI 10.1681/ASN.V1191712
[6]   GENETIC-BASIS OF ENDOCRINE DISEASE .5. MOLECULAR-GENETICS OF PARATHYROID-GLAND NEOPLASIA [J].
ARNOLD, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (05) :1108-1112
[7]   CALCIUM MODULATES THE CYCLIN D1 EXPRESSION IN A RAT PARATHYROID CELL-LINE [J].
BIANCHI, S ;
FABIANI, S ;
MURATORI, M ;
ARNOLD, A ;
SAKAGUCHI, K ;
MIKI, T ;
BRANDI, ML .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 204 (02) :691-700
[8]   Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study [J].
Block, GA ;
Hulbert-Shearon, TE ;
Levin, NW ;
Port, FK .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 31 (04) :607-617
[9]   PHOSPHOLIPASE-A2 ACTION AND ARACHIDONIC-ACID METABOLISM IN CALCIUM-MEDIATED PARATHYROID-HORMONE SECRETION [J].
BOURDEAU, A ;
SOUBERBIELLE, JC ;
BONNET, P ;
HERVIAUX, P ;
SACHS, C ;
LIEBERHERR, M .
ENDOCRINOLOGY, 1992, 130 (03) :1339-1344
[10]   EFFECTS OF LIPOXYGENASE PRODUCTS OF ARACHIDONATE METABOLISM ON PARATHYROID-HORMONE SECRETION [J].
BOURDEAU, A ;
MOUTAHIR, M ;
SOUBERBIELLE, JC ;
BONNET, P ;
HERVIAUX, P ;
SACHS, C ;
LIEBERHERR, M .
ENDOCRINOLOGY, 1994, 135 (03) :1109-1112